Onconic Therapeutics Inc. (KOSDAQ:476060)
16,370
-140 (-0.85%)
Dec 10, 2025, 3:30 PM KST
| Market Cap | 734.53B |
| Revenue (ttm) | 46.65B |
| Net Income (ttm) | 16.75B |
| Shares Out | 44.49M |
| EPS (ttm) | 1,513.84 |
| PE Ratio | 10.91 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,043,710 |
| Average Volume | 5,032,330 |
| Open | 16,400 |
| Previous Close | 16,510 |
| Day's Range | 15,930 - 16,710 |
| 52-Week Range | 3,138 - 26,600 |
| Beta | n/a |
| RSI | 45.99 |
| Earnings Date | Nov 11, 2025 |